LE MALATTIE REUMATICHE AUTOIMMUNI: PERCHE' DONNA? PERCHE' NON UOMO? NUOVE TERAPIE PER NUOVI ORIZZONTI - martedì 8 ottobre, ore 10 - Associazione ...
←
→
Trascrizione del contenuto della pagina
Se il tuo browser non visualizza correttamente la pagina, ti preghiamo di leggere il contenuto della pagina quaggiù
martedì 8 ottobre, ore 10 LE MALATTIE REUMATICHE AUTOIMMUNI: PERCHE’ DONNA? PERCHE’ NON UOMO? NUOVE TERAPIE PER NUOVI ORIZZONTI Renato Carignola, immunologo Claudia Lomater, reumatologo
La medicina ha ignorato per lungo tempo la differenza fra uomini e donne: • che si ammalano in modo diverso, • presentano gravità di sintomi e decorso diversi per la stessa patologia, • hanno risposte diverse rispetto all’assunzione di farmaci, • hanno diversa sopravvivenza alla stessa patologia.
Il sistema immunitario e il sesso L’incidenza di influenza stagionale è più alta negli uomini che nelle donne il rischio di morte per tumore è di 1.6 volte maggiore negli uomini che nelle donne
…ma… …quando le cellule del sistema immunitario sono esposte a virus, batteri, parassiti, allergeni, tossine o antigeni «self»… la risposta immunitaria di una donna differisce da quella di un uomo!
Women - enhanced antibody production - increased cell-mediated responses following immunization - higher CD4+ T cell counts - increased CD4/CD8 ratio - Higher levels of plasma IgM - greater Th1 cytokine production Men: - produce a more intense inflammatory response to infectious organisms The significance of these changes remain poorly defined since there does not appear to be significant differences in susceptibility to infection or inflammation degrees between sexes
«Nelle malattie reumatiche/autoimmuni le differenze tra uomini e donne sono rappresentate dalla: diversa frequenza, gravità dei sintomi, decorso della malattia, e risposta alla terapia. Recenti evidenze di una differente risposta delle donne rispetto agli uomini al trattamento con farmaci biologici quali gli anticorpi anti-TNFα (usati per esempio nella terapia dell’artrite reumatoide e delle malattie infiammatorie croniche intestinali) indicano la forte necessità di costruire percorsi terapeutici personalizzati in base al genere anche al fine di un’ottimizzazione dei budget sanitari» Marina Pierdominici - ISS
M.Chagall. La passeggiata, 1917-1918
Le malattie autoimmuni coinvolgono circa il 5% della popolazione generale Torino ∼ 878000 abitanti ∼ 43900 pazienti Circa l'80% dei pazienti con malattie autoimmuni sono donne ∼ 35100 pazienti Dati ISTAT
9:1 – 50:1 The role of gender and organ specific autoimmunity. U. Nussinovitch. Autoimmuity reviews 2011
Tale predominanza epidemiologica si riferisce a una differenza di „sesso“ o di genere? S. Oertelt-Prigione. Autoimmunity Reviews, 11, 2012.
Systemic lupus erythematosus (SLE) SLE has a significant predominance in women. It tends to worsen during pregnancy and to remit after menopause. This suggests that sex hormones are crucial for SLE regulation. imbalance between hormone relationships with lower immune- suppressive androgens and higher immunoenhancing estrogens lower androgen levels than healthy women SLE-men with elevated serum levels of 16-hydroxyestrone and estrone hypoandrogenism, low levels of testosterone and elevated levels of luteinizing hormone (testosterone is thought to suppress anti-double stranded DNA antibody production) About 22-33% of SLE patients have mild to severe hyperprolactinemia. Prolactin leads to the production of interferon-gamma which is an important mediator in lupus nephritis. Bromocriptine, an inhibitor of prolactin secretion, has shown beneficial effects in both murines and humans.
Sjögren’s syndrome (SS) This disease is also one of the most prevalent ADs among women. SS primarily affects women during the fourth and fifth decades of life. In men SS is uncommon. Women with SS have more anti-Ro antibodies and Raynaud’s phenomenon than men. Men with SS are at higher risk for lymphoma and neurological involvement than women. Accordingly, male gender should be considered as a new risk factor for lymphoma development in patients with SS.
Journal of Autoimmunity 2012, 38; j109 - j119
Estrogens and androgens are hormones that have been studied for increasing susceptibility to Autoimmune Diseases. They can affect both innate and adaptive immune systems. • Estrogens seem to direct the immune system to T- helper 2 lymphocyte dominance more B cell activation and antibody production. • Androgen favors the development of a T-helper 1 response and CD8+ cell activation.
Tai-Ping Lee, et all. Autoimmunity rewiev 2012
Non così di corsa...
Secreetion of cytokines and chemokines Macrophages Release of reactive oxygen species Proliferation T cells Adhesion to endothelial cells Proliferation B cells Secretion of IgM and IgG Prolactin Activation of STAT1 and MAPK pathways Granulocytes Transcription of IRF-1 and iNOS Proliferation and cytotoxic activity Natural killr cells Release of IFN-Ƴ Antigen presentation Dendritic cells Expression of CD80/86 and MHC II
Hyperprolactinemia and autoimmune deseases Systemic diseases Organ-specific diseases Type 1 diabetes Multiple sclerosis Systemic lupus erythematosus Myasthenia gravis Anti-phospholipid syndrome Pemphigus vulgaris Rheumatoid arthritis Psoriasis vulgaris Psoriatic arthritis Celiac disease Sjögren syndrome Autoimmune thyroid disease Systemic sclerosis Autoimmune uveitis Addison's disease Behçet ́s disease Lymphocytic hypophysitis Reactive arthritis Peripartum cardiomyopathy Rejection of heart transplantation
Prolactin and autoimmunity. S. Shelly et al. Autoimmunity Reviews 11 (2012)
Le tre età della donna - G. Klimt, 1905
Other hormonal influences… Changes in the disease severity during menses and menopause are described. In young patients, an early age at menarche has been associated with doubling the risk of SLE and RA. Also the worsening of symptoms in RA, SLE and MS has been reported prior to the onset of menses. In older women, RA has a high incidence at menopause while onset of SLE is less common in postmenopausal women. The use of oral contraceptives in MS is associated with a decrease in disease incidence. In SLE, their use is associated with disease exacerbation and the safety of estrogens in lupus erythematosus national assessment (SELENA) study shows that hormone replacement therapy with estrogens can induce mild exacerbations.
Le tre età della donna - G. Klimt, 1905 (particolare)
Pregnancy… Signs and symptoms of MS and RA lessen during pregnancy and postpartum may be associated with disease exacerbation. SLE is often exacerbated during pregnancy and disease activity is associated with a worse fetal outcome. Pregnancy may induce changes in the maternal immune system in order to protect the fetus. A shift from the prevailing Th1 response to a type Th2 could be seen and attributed to an increased progesterone level. Also, pregnant women have enhanced immunoglobulin production and an increased production of autoantibodies. A worse pregnancy outcome has been found in SLE patients with glomerulonephritis being the main disease manifestation threatening both maternal and fetal health.
Le malattie autoimmuni: „dazio“ per un maggior successo riproduttivo. Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? Human Reproduction 2008
Il microchimerismo
Gender as risk factor for autoimmune diseases. Norbert Gleicher e all. Journal of autoimmunity 2007
E se la domanda fosse… Perché non gli uomini? Salvador Dali. Self Portrait as Mona Lisa. 1954
Tali dati non sono univocamente accettati in letteratura; vi è però consenso circa la maggior presenza di complicanze delle malattie autoimmuni nei maschi. C. Doukas et al, Rheumatol Int 2012 .
Olga L. Quintero et all. Journal of Autoimmunity, 2012
G. de Chirico. Ettore e Andromaca, 1917
I fattori genetici
The female X-inactivation mosaic in systemic lupus erythematosuss. J.J. Stewart. Immunology today 1998
The female X-inactivation mosaic in systemic lupus erythematosuss. J.J. Stewart. Immunology today 1998
The female X-inactivation mosaic in systemic lupus erythematosuss. J.J. Stewart. Immunology today 1998
The X chromosome and the sex ratio of autoimmunity. Carlo Selmi e coll. Immunity Rewiev 2011
Epigenetics and Autoimmune Diseases. P.Q. Ronderos et all. Autoimmune Diseases 2012
E le differenze di genere?
L’importanza della dieta… L’esempio dell’emocromatosi in Sicilia per difetto del C282Y-gene. → Mutazione del gene HFE, C282Y, H63D a S65C → emocromatosi ereditaria → incapacità di formare un eterodimero con la beta2- microglobulina → abnorme assorbimento del ferro (da 2 a 3 volte) → dieta a basso introito di ferro (acarnea) per le donne a inizio ‘900 (carne come alimento solo per gli uomini) NO MALATTIA
K Razumof. 1974
Problema: esiste una correlazione tra lutilizzo del rossetto e linsorgenza delle malattie autoimmuni nel sesso femminile?
M.Chagall. La passeggiata, 1917-1918
…to be a woman is something so strange, so confusing and so complicated that only a woman could put up with it. Kierkegaard
Grazie per la attenzione! S. Dalì. La Venere di Milo con cassetti, 1936
Puoi anche leggere